These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24636920)

  • 1. Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.
    Ari C; Borysov SI; Wu J; Padmanabhan J; Potter H
    Neurobiol Aging; 2014 Aug; 35(8):1839-49. PubMed ID: 24636920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.
    Freund RK; Gibson ES; Potter H; Dell'Acqua ML
    Mol Pharmacol; 2016 May; 89(5):552-9. PubMed ID: 26957206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition.
    Kroker KS; Mathis C; Marti A; Cassel JC; Rosenbrock H; Dorner-Ciossek C
    Neurobiol Aging; 2014 Sep; 35(9):2072-8. PubMed ID: 24746365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo.
    Knowles JK; Rajadas J; Nguyen TV; Yang T; LeMieux MC; Vander Griend L; Ishikawa C; Massa SM; Wyss-Coray T; Longo FM
    J Neurosci; 2009 Aug; 29(34):10627-37. PubMed ID: 19710315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release.
    Ferreira IL; Ferreiro E; Schmidt J; Cardoso JM; Pereira CM; Carvalho AL; Oliveira CR; Rego AC
    Neurobiol Aging; 2015 Feb; 36(2):680-92. PubMed ID: 25442114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors.
    Borysov SI; Granic A; Padmanabhan J; Walczak CE; Potter H
    Cell Cycle; 2011 May; 10(9):1397-410. PubMed ID: 21566458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
    DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
    Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
    Maliga Z; Kapoor TM; Mitchison TJ
    Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytic N-Methyl-D-Aspartate Receptors Protect the Hippocampal Neurons Against Amyloid-β142-Induced Synaptotoxicity by Regulating Nerve Growth Factor.
    Song Y; Du Z; Chen X; Zhang W; Zhang G; Li H; Chang L; Wu Y
    J Alzheimers Dis; 2022; 85(1):167-178. PubMed ID: 34776441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease.
    Shi XD; Sun K; Hu R; Liu XY; Hu QM; Sun XY; Yao B; Sun N; Hao JR; Wei P; Han Y; Gao C
    J Neurosci; 2016 Nov; 36(47):11959-11973. PubMed ID: 27881781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of p75 neurotrophin receptor ameliorates the cognitive deficits in a model of Alzheimer's disease.
    Murphy M; Wilson YM; Vargas E; Munro KM; Smith B; Huang A; Li QX; Xiao J; Masters CL; Reid CA; Barrett GL
    Neurobiol Aging; 2015 Feb; 36(2):740-52. PubMed ID: 25443284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin type 6 receptor antagonist attenuates the impairment of long-term potentiation and memory induced by Abeta.
    Shahidi S; Hashemi-Firouzi N; Asl SS; Komaki A
    Behav Brain Res; 2019 May; 364():205-212. PubMed ID: 30735758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice.
    Liu MY; Wang S; Yao WF; Zhang ZJ; Zhong X; Sha L; He M; Zheng ZH; Wei MJ
    Neuroscience; 2014 Jul; 273():141-51. PubMed ID: 24846616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
    Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
    Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease.
    Small DH; Fodero LR
    J Alzheimers Dis; 2002 Oct; 4(5):349-55. PubMed ID: 12446967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain.
    Abad MA; Enguita M; DeGregorio-Rocasolano N; Ferrer I; Trullas R
    J Neurosci; 2006 Dec; 26(49):12735-47. PubMed ID: 17151277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.